News

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, announced plans to invest $59 million to significantly expand its laboratory…
Read More...

PTC Therapeutics, Inc. announced that it has entered into a strategic financing collaboration with funds managed by Blackstone to support its mission to reach a steady-state of…
Read More...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced that the European Medicines Agency (EMA) has…
Read More...

2seventy bio, Inc. and JW Therapeutics announced a strategic alliance to establish a translational and clinical cell therapy development platform designed to more rapidly explore T…
Read More...

Seres Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for investigational oral microbiome…
Read More...

Global biotechnology leader CSL announced the company has entered into a Strategic Option and License Agreement with Arizona-based Translational Sciences for their enhanced thrombus…
Read More...

WuXi Biologics announced it has successfully launched its drug substance GMP manufacturing facility (named MFG8) located in Shijiazhuang, Hebei Province, China. MFG8 is the 11th…
Read More...

NovAccess Global Inc. announced the approval of its application with the U.S. Food and Drug Administration (FDA) for Orphan Drug Designation (ODD) for TLR-AD1, a vaccine immunotherapy…
Read More...

Bayer Inc. announced that Health Canada approved finerenone, under the brand name KERENDIA, as an adjunct to standard of care therapy in adults with chronic kidney disease (CKD) and…
Read More...

Normunity, Inc., a biotechnology company creating novel precision anti-cancer immunotherapies, announced its launch and Series A financing of $65 million. The Series A was led by Canaan…
Read More...

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across the globe, announced that the Company made a new…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) approved TECVAYLI (teclistamab-cqyv) for the treatment of adult…
Read More...

FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, announced a strategic…
Read More...

BioMed X announced the launch of their first joint research project with Sanofi. As part of this, a new research group to be established at the BioMed X Institute in Heidelberg,…
Read More...

AstraZeneca’s Imjudo (tremelimumab) in combination with Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with unresectable hepatocellular carcinoma…
Read More...

Astellas Pharma Inc. and Taysha Gene Therapies, Inc. announced a strategic investment to support the advancement of Taysha's adeno-associated virus (AAV) gene therapy development…
Read More...

Daiichi Sankyo received notification of acceptance by the U.S. Food and Drug Administration (FDA) of the New Drug Application (NDA) of quizartinib in combination with standard…
Read More...

Kite, a Gilead Company and Refuge Biotechnologies, Inc. announced that Kite has entered into an exclusive, worldwide license agreement with Refuge, a synthetic biology company for…
Read More...

ARS Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review ARS’ New Drug Application (NDA) for neffy for the emergency treatment…
Read More...

Sumitovant Biopharma Ltd. in conjunction with parent company Sumitomo Pharma Co., Ltd. and Myovant Sciences announced today that they have entered into a definitive agreement pursuant…
Read More...